ucb0107
mAbexperimental
Clinical trial activity
5 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 16, 2018 (NCT03464227)
Timeline
Indications
Mechanism of action
- Microtubule-associated protein tauINHIBITOR
Microtubule-associated protein tau inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594612 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04867616 | Phase 2 | Jun 9, 2021 | UCB |
| NCT04658199 | Phase 1 | Dec 31, 2020 | UCB |
| NCT04185415 | Phase 1 | Dec 31, 2019 | UCB |
| NCT03605082 | Phase 1 | Jul 25, 2018 | UCB |
| NCT03464227 | Phase 1 | Feb 16, 2018 | UCB |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| UCB | For profit | 5 | 5 | 2 | 2018 |
1 organizations
Page 1 / 1